Amniotic Fluid and Maternal Serum Levels of CA125 in Pregnancies affected by Down Syndrome: a Re-evaluation of the Role of CA125 in Down Syndrome Screening
- 1 August 1997
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 17 (8) , 701-706
- https://doi.org/10.1002/(sici)1097-0223(199708)17:8<701::aid-pd135>3.0.co;2-f
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Abnormal amniotic fluid levels of CA 125 in second‐trimester Down syndrome pregnanciesPrenatal Diagnosis, 1993
- Maternal serum CA 125 levels in pregnancies with chromosomally‐normal and ‐abnormal fetusesPrenatal Diagnosis, 1993
- Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.BMJ, 1993
- Second-trimester cancer antigen 125 and Down's syndromePrenatal Diagnosis, 1992
- The prognostic significance of maternal serum CA125 measurement in threatened abortionEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1992
- Maternal Serum CA 125 for aneuploidy detection in early pregnancyPrenatal Diagnosis, 1992
- CA‐125 as a maternal serum marker for Down's syndrome in the first and second trimestersPrenatal Diagnosis, 1992
- First trimester CA 125 and Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1991
- Evaluation of Serum CA125 Values in Healthy Individuals and Pregnant WomenThe Lancet Healthy Longevity, 1986
- CONCENTRATION OF CHORIONIC GONADOTROPHIN AND CHORIONIC SOMATOMAMMOTROPHIN IN MATERNAL SERUM, AMNIOTIC FLUID AND CORD BLOOD SERUM AT TERMBJOG: An International Journal of Obstetrics and Gynaecology, 1972